Dotmatics

NBC News: How AI is Transforming Drug Discovery

In an NBC News segment, Alister Campbell, VP of Dotmatics, explains how the company leverages AI to analyze large datasets, predict effective drug compounds, and streamline drug discovery by replacing fragmented data systems and manual workflows with integrated AI-driven scientific platforms that enable faster, smarter research decisions.

NBC News: How AI is Transforming Drug Discovery

Latest Blogs

Case Studies

White Papers

Upcoming Events

News

Search

In a recent segment of NBC news feature, Alister Campbell, VP of Dotmatics, discusses how AI is used to analyze massive datasets, predict which compounds are most likely to work, and reduce the trial and error that can slow drug development for years.

Campbell explains how Dotmatics is helping customers move beyond fragmented data systems and manual workflows by integrating AI into their scientific platforms, enabling researchers to design better experiments and make faster, smarter decisions.

Watch the full segment to hear how Dotmatics is reshaping the future of scientific discovery with AI.